Basilea Pharmaceutica
Présence
Basilea Pharmaceutica est une société cotée sous le symbole boursier BPMUF (CH).
Dirigeants
Voir l'organigramme avec ses 11 principaux dirigeants
Biographies les plus recherchées chez Basilea Pharmaceutica
- David Veitch, Chief Executive Officer
- Martin Nicklasson, Member of the Board of Directors
- Domenico Scala, Chairman of the Board
Créer une alerte
pour suivre les mouvements de dirigeants chez Basilea Pharmaceutica.
Pharmacie
Basilea Pharmaceutica a 1 863 concurrents dont Pfizer (Etats—Unis), Sanofi (France) et Johnson & Johnson (Etats—Unis).
Actualités en fusion/acquisition en Pharmacie.
- AstraZeneca has announced the acquisition of Fusion Pharma (publié le 23 mars 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publié le 19 mars 2024).
- Frontier Medicines vient d'annoncer une levée de fonds de 80 millions de dollars. (publié le 27 février 2024).
Contacts en Pharmacie
Actualités
Derniers communiqués de presse par Basilea Pharmaceutica
- https://www.basilea.com/news/news/basilea-awarded-carb-x-grant-to-develop-recently-acquired-novel-class-of-antibiotics?type=1546938654
- https://www.basilea.com/news/news/basilea-announces-us-fda-approval-of-antibiotic-zevterar-ceftobiprole-medocaril-for-three-indications?type=1546938654
- https://www.basilea.com/news/news/continued-strong-cresembar-isavuconazole-sales-performance-in-asia-pacific-and-china-triggers-milestone-payment-to-basilea?type=1546938654
- https://www.basilea.com/news/news/basilea-reports-strong-2023-full-year-results-with-profitability-significantly-above-guidance-whilst-substantially-expanding-the-rd-portfolio?type=1546938654
- https://www.basilea.com/news/news/basilea-announces-acquisition-of-preclinical-antibiotics-program-from-spexis?type=1546938654
- https://www.basilea.com/news/news/cresembar-sales-in-latin-america-trigger-first-sales-milestone-payment-to-basilea?type=1546938654
- https://www.basilea.com/news/news/basilea-provides-portfolio-status-update?type=1546938654
- https://www.basilea.com/news/news/basilea-announces-accelerated-loan-repayment?type=1546938654
- https://www.basilea.com/news/news/basilea-announces-that-fda-approves-expanded-use-of-antifungal-cresembar-isavuconazole-in-the-united-states-in-children-with-invasive-aspergillosis-and-invasive-mucormycosis?type=1546938654
- https://www.basilea.com/news/news/continued-strong-cresembar-isavuconazole-sales-performance-in-asia-pacific-and-china-triggers-third-sales-milestone-payment-for-the-region-from-pfizer-this-year?type=1546938654
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Basilea Pharmaceutica
- Basilea Pharmaceutica sur Wikipédia, Google News & Yahoo Finance en 1-click
- Basilea Pharmaceutica sur LinkedIn, Twitter & YouTube en 1-click
Entrer en contact
Contacter par email ses dirigeants dont David Veitch 
Appelez Basilea Pharmaceutica au +41 61...
